What did @clairecelestes actually say?
Not much, technically. She broke her foot, she's trying "peptide" once a day for 30 days, and it's "supposed to help with promote healing and recovery." That's the entire medical claim. She never names which peptide she's injecting, which makes fact-checking the specifics genuinely difficult. The bulk of the video is injection technique, including bending the needle, stabbing herself in the abdomen, and asking followers for tips on how not to mess it up. Credit where it's due: she cleaned the vial top and the injection site. Those are the right moves. But the undefined "peptide" claim and the visible technique struggles raise real questions worth unpacking.
Does the science back this up?
It depends enormously on which peptide she's actually using, and she never says. The two most commonly self-administered peptides for injury recovery are BPC-157 and TB-500 (a thymosin beta-4 fragment). The evidence base for each is thin and almost entirely preclinical. For BPC-157, studies in rodent models, including research by Sikiric et al. published repeatedly in Current Pharmaceutical Design through the 2010s, show accelerated tendon, ligament, and bone healing. But rodent data does not translate cleanly to humans, and no large randomized controlled trials in humans exist. TB-500 has even less human data. A 30-day subcutaneous protocol is a common community standard, but it is not derived from clinical trial methodology. It is derived from peptide forums and anecdote. If she's expecting the kind of evidence base that, say, teriparatide (an FDA-approved bone-building peptide drug) has behind it, she will be disappointed. That drug has phase III trials. Her peptide does not.
What did they get wrong, or right?
She got the injection site right. Subcutaneous abdominal injection below the navel is a legitimate and widely used site for peptide administration, with good subcutaneous tissue depth and consistent absorption. Cleaning the vial septum and the skin surface are correct steps. That part checks out.
What's missing is concerning, though. She mentions bending the needle, which can happen when you angle the needle too sharply rather than pinching the skin and inserting at a 45-to-90-degree angle depending on body composition. More importantly, she never mentions:
- Reconstitution details. If this is a lyophilized powder, she appears to be drawing from a vial, but the reconstitution process matters for dosing accuracy.
- Cold storage. Most peptides degrade rapidly at room temperature once reconstituted.
- Sourcing. Compounded and research-grade peptides vary significantly in purity. Without third-party testing, you do not actually know what is in the vial.
The casual "I might be doing this part wrong" framing is honest but also genuinely risky when you are injecting an unregulated compound into your body.
What should you actually know?
Peptide therapy for injury recovery sits in a legal and evidentiary gray zone. Some peptides, like BPC-157, remain unapproved by the FDA for any human indication. The FDA issued guidance in 2023 restricting certain peptides from compounding pharmacies, which has reshuffled the supply chain in ways that affect product quality and consistency. A study by Hardy et al. (2023, Frontiers in Pharmacology) reviewing GH-secretagogues and healing peptides noted the gap between animal model promise and human clinical evidence is substantial and unresolved. If you have a fracture, there is a real treatment pathway, namely orthopedic care, calcium and vitamin D adequacy, and in some cases pharmaceutical intervention. Adding an unnamed peptide to that is not automatically harmful, but it is not evidence-based either. Anyone self-injecting peptides for injury recovery should at minimum know exactly what compound they are using, verify sourcing, store it correctly, and have a clinician who is actually aware they are doing it.